The IL-6 feed-forward loop: A driver of tumorigenesis

被引：87
作者：
Chang, Qing [1 ]
Daly, Laura [1 ]
Bromberg, Jacqueline [1 ,2 ]
机构：
[1] MSKCC, Dept Med, New York, NY 10065 USA
[2] WCMC, New York, NY USA
来源：
SEMINARS IN IMMUNOLOGY | 2014年 / 26卷 / 01期
关键词：
Metastasis; Microenvironment; Cancer; MESENCHYMAL STEM-CELLS; NF-KAPPA-B; ANTI-INTERLEUKIN-6; MONOCLONAL-ANTIBODY; DUCTAL BREAST-CARCINOMA; LIGAND-INDUCED ENDOCYTOSIS; SILTUXIMAB CNTO 328; SUPPRESSOR-CELLS; MULTIPLE-MYELOMA; STAT3; ACTIVATION; CANCER-CELLS;
D O I：
10.1016/j.smim.2014.01.007
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
IL-6 signaling plays a prominent role in tumorigenesis and metastasis. In this review we discuss the recent evidence describing the tumor intrinsic and extrinsic functions of this signaling pathway. Although blockade of this pathway in pre-clinical models leads to a reduction in tumor growth and metastasis, its clinical success is less evident. Thus, identifying the features of tumors/patients that predict response to anti-IL6 therapy are needed. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码：48 / 53
页数：6
相关论文
共 120 条
[31]   Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer [J].
Fizazi, K. ;
De Bono, J. S. ;
Flechon, A. ;
Heidenreich, A. ;
Voog, E. ;
Davis, N. B. ;
Qi, Ming ;
Bandekar, R. ;
Vermeulen, J. T. ;
Cornfeld, M. ;
Hudes, G. R. .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (01) :85-93
[32]   Myeloid-derived suppressor cells as regulators of the immune system [J].
Gabrilovich, Dmitry I. ;
Nagaraj, Srinivas .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (03) :162-174
[33]   Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas [J].
Gao, Sizhi Paul ;
Mark, Kevin G. ;
Leslie, Kenneth ;
Pao, William ;
Motoi, Noriko ;
Gerald, William L. ;
Travis, William D. ;
Bornmann, William ;
Veach, Darren ;
Clarkson, Bayard ;
Bromberg, Jacqueline F. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :3846-3856
[34]   An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer [J].
Garbers, Christoph ;
Spudy, Bjoern ;
Aparicio-Siegmund, Samadhi ;
Waetzig, Georg H. ;
Sommer, Jan ;
Hoelscher, Christoph ;
Rose-John, Stefan ;
Groetzinger, Joachim ;
Lorenzen, Inken ;
Scheller, Juergen .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (06) :4346-4354
[35]   Perspectives in the treatment of multiple myeloma [J].
Gentile, Massimo ;
Recchia, Anna Grazia ;
Mazzone, Carla ;
Lucia, Eugenio ;
Vigna, Ernesto ;
Morabito, Fortunato .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 :S1-S22
[36]   Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells [J].
Gerlo, Sarah ;
Haegeman, Guy ;
Vanden Berghe, Wim .
CELLULAR SIGNALLING, 2008, 20 (08) :1489-1496
[37]   Autocrine IL-6 signaling: A key event in tumorigenesis? [J].
Grivennikov, Sergei ;
Karin, Michael .
CANCER CELL, 2008, 13 (01) :7-9
[38]   IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer [J].
Grivennikov, Sergei ;
Karin, Eliad ;
Terzic, Janos ;
Mucida, Daniel ;
Yu, Guann-Yi ;
Vallabhapurapu, Sivakumar ;
Scheller, Juergen ;
Rose-John, Stefan ;
Cheroutre, Hilde ;
Eckmann, Lars ;
Karin, Michael .
CANCER CELL, 2009, 15 (02) :103-113
[39]   REGULATION OF INTERLEUKIN-6 (IL-6) EXPRESSION - EVIDENCE FOR A TISSUE-SPECIFIC ROLE OF PROTEIN-KINASE-C [J].
GROSS, V ;
ZHANG, BP ;
GENG, Y ;
VILLIGER, PM ;
LOTZ, M .
JOURNAL OF CLINICAL IMMUNOLOGY, 1993, 13 (05) :310-320
[40]   Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer [J].
Guo, Yuqi ;
Nemeth, Jeffrey ;
O'Brien, Colin ;
Susa, Michiro ;
Liu, Xianzhe ;
Zhang, Zhan ;
Choy, Edwin ;
Mankin, Henry ;
Hornicek, Francis ;
Duan, Zhenfeng .
CLINICAL CANCER RESEARCH, 2010, 16 (23) :5759-5769
12345678910